Anti-adhesive prevention of Chlamydia trachomatis genital tract infection
Anti-adhesive prevention of Chlamydia trachomatis genital tract infection
批准号:
7898727
负责人:
LEE ANN CAMPBELL
金额:
$23.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-23 至 2012-06-30
关键词:
AdhesivesBindingBiological AssayBody FluidsCarbohydratesCell Culture TechniquesCell surfaceCellsCenters for Disease Control and Prevention (U.S.)CervicalCervicitisChlamydiaChlamydia trachomatisCreamDevelopmentDevicesDiseaseDrug FormulationsEctopic PregnancyEndometritisEpithelial CellsExcisionFilmGelGenital systemGlycoproteinsGoalsGram&aposs stainGrantHumanImmunobiologyIn VitroInfectionInfection preventionInfertilityInflammationLigandsLocal MicrobicidesLungMacaca nemestrinaMannansMannoseMethodsModelingMorbidity - disease rateMucous MembraneOligosaccharidesOrganismOutcomeOvalbuminPelvic Inflammatory DiseasePneumoniaPolysaccharidesPreventionPrevention strategyPreventivePrimatesPublic HealthReportingResearch PersonnelSafetySalpingitisScreening procedureSexually Transmitted DiseasesStructureSubgroupTestingTissuesUnited StatesVaccinesVaginaWomanbasecombatcostcytokinedisorder preventionefficacy testinggenital infectiongenital secretionglobal healthimmunogenicin vivoinflammatory markerinhibitor/antagonistmajor outer membrane proteinmannose receptormicrobialmicrobicidemouse modelnovelnovel strategiesobligate intracellular parasitepathogenpreclinical studypreventpublic health relevancereceptorreproductiveroutine Bacterial stainsugartissue/cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Sexually transmitted infections (STIs) have a huge impact on public health. Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections globally, and is the most prevalent sexually transmitted diseases in the United State, with an estimated 3 to 4 million cases in the United States per year. Infection of the mucosa results in cervicitis, endometritis, and salpingitis. The pathological consequences of untreated infections may result in severe reproductive tract disease including pelvic inflammatory disease (PID), ectopic pregnancy and infertility. Despite the high morbidity and cost burden, there are currently no effective vaccines. A promising alternative preventive approach is the use of topical microbicides that can be applied intravaginally in a gel, cream, or other formulation. Key to the development of effective strategies for preventing infection of this obligate intracellular pathogen is to prevent attachment and internalization. In this study, we propose to test the feasibility of using high mannose oligosaccharides as a novel topical microbicide for preventing C trachomatis infection. This approach is based on our studies demonstrating that the chlamydial glycan, a high mannose oligosaccharide, is key to attachment and infectivity by binding to the mannose receptor on host cells. Significantly, high mannose oligosaccharides or removal of the glycan inhibit infectivity in vitro in cell culture and in vivo in a mouse model of lung infection. Thus, we will test the hypothesis that high mannose oligosaccharides will be an effective anti-adhesive prevention method for C. trachomatis genital tract infection. This will be accomplished in vitro by determining the efficacy of high mannose oiigosaccharides in inhibiting infectivity of C. trachomatis genital serovars in vitro and in vivo in a mouse model of genital tract infection. PUBLIC HEALTH RELEVANCE: Chlamydia trachomatis is the leading cause of sexually transmitted infection in the US with severe outcomes in women including pelvic inflammatory disease, ectopic pregnancy and infertility. This proposal seeks to determine the feasibility of a novel anti-adhesive prevention method that could be used as a topical microbicide to prevent genital tract infection with this pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chlamydia pneumoniae persistance in the blood vessel
-
批准号:9031212
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2016
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia virulence: exploitation of host N-glycosylation
-
批准号:8753572
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2014
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia virulence: exploitation of host N-glycosylation
-
批准号:9390739
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2014
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Anti-adhesive prevention of Chlamydia trachomatis genital tract infection
-
批准号:7707140
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2009
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia pneumoniae Antigens of Biological Significance
-
批准号:7026454
-
项目类别:
-
资助金额:$33.31万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia Pneumoniae Antigens of Bilogogical Significance
-
批准号:7522452
-
项目类别:
-
资助金额:$39.0万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia Pneumoniae Antigens of Bilogogical Significance
-
批准号:7792341
-
项目类别:
-
资助金额:$38.61万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
-
批准号:2637348
-
项目类别:
-
资助金额:$23.66万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
-
批准号:2887732
-
项目类别:
-
资助金额:$24.15万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia pneumoniae Antigens of Biological Significance
-
批准号:6624069
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia pneumoniae Antigens of Biological Significance
-
批准号:6877105
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia Pneumoniae Antigens of Bilogogical Significance
-
批准号:7621048
-
项目类别:
-
资助金额:$39.0万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
-
批准号:6170907
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia pneumoniae Antigens of Biological Significance
-
批准号:6472104
-
项目类别:
-
资助金额:$34.13万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia pneumoniae Antigens of Biological Significance
-
批准号:6736273
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
-
批准号:6373832
-
项目类别:
-
资助金额:$25.67万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia Pneumoniae Antigens of Bilogogical Significance
-
批准号:8259772
-
项目类别:
-
资助金额:$38.22万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Chlamydia Pneumoniae Antigens of Bilogogical Significance
-
批准号:8064417
-
项目类别:
-
资助金额:$38.22万
-
财政年份:1998
-
负责人:LEE ANN CAMPBELL
-
依托单位:
Diseases of Public Health Importance
-
批准号:6796351
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1997
-
负责人:LEE ANN CAMPBELL
-
依托单位:
DISEASES OF PUBLIC HEALTH IMPORTANCE
-
批准号:2886236
-
项目类别:
-
资助金额:$13.27万
-
财政年份:1997
-
负责人:LEE ANN CAMPBELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: